# FDA Inspection 1143134 - CTI Biopharma Corp - May 25, 2021

Source: https://www.keypedia.com/records/fda_inspections/cti-biopharma-corp/e45d5fde-e0f8-4e6b-8c75-f2dd84729545
Source feed: FDA_Inspections

> FDA Inspection 1143134 for CTI Biopharma Corp on May 25, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1143134
- Company Name: CTI Biopharma Corp
- Inspection Date: 2021-05-25
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 628277 - 2009-11-18](https://www.keypedia.com/records/fda_inspections/cti-biopharma-corp/0bac42bb-b407-4497-9021-80c55accdf54)

Company: https://www.keypedia.com/companies/cti-biopharma-corp/889b5609-a75d-43f9-8789-a4930350527b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c